Definitive Healthcare lowers Q2 EPS guidance to $0.08-$0.09 and revenue to $62.0-$63.5m, below consensus estimates.
Definitive Healthcare (NASDAQ: DH) updated its Q2 EPS guidance to $0.08-$0.09, lower than consensus estimates, and its revenue guidance to $62.0-$63.5m, also below expectations. Despite this, the company's Q1 2024 revenue increased by 7% YoY to $63.5m and adjusted EBITDA grew to $20m (32% of revenue). The firm has a market cap of $853.98m, a PE ratio of -4.07, and a beta of 1.41.
May 07, 2024
3 Articles